Potassium hydroxide structure
|
Common Name | Potassium hydroxide | ||
---|---|---|---|---|
CAS Number | 1310-58-3 | Molecular Weight | 56.106 | |
Density | 1.450 g/mL at 20 °C | Boiling Point | 1320°C | |
Molecular Formula | HKO | Melting Point | 361 °C(lit.) | |
MSDS | Chinese USA | Flash Point | 52 °F | |
Symbol |
GHS05, GHS07 |
Signal Word | Danger |
Name | potassium hydroxide |
---|---|
Synonym | More Synonyms |
Density | 1.450 g/mL at 20 °C |
---|---|
Boiling Point | 1320°C |
Melting Point | 361 °C(lit.) |
Molecular Formula | HKO |
Molecular Weight | 56.106 |
Flash Point | 52 °F |
Exact Mass | 55.966446 |
PSA | 23.06000 |
Vapour Pressure | 1 mm Hg ( 719 °C) |
Index of Refraction | n20/D 1.421 |
Water Solubility | soluble |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
MUTATION DATA
|
Symbol |
GHS05, GHS07 |
---|---|
Signal Word | Danger |
Hazard Statements | H290-H302-H314 |
Precautionary Statements | P280-P301 + P312 + P330-P303 + P361 + P353-P304 + P340 + P310-P305 + P351 + P338 |
Personal Protective Equipment | Faceshields;full-face respirator (US);Gloves;Goggles;multi-purpose combination respirator cartridge (US);type ABEK (EN14387) respirator filter |
Hazard Codes | C: Corrosive;F: Flammable;T: Toxic;Xi: Irritant; |
Risk Phrases | R22;R35 |
Safety Phrases | S7-S16-S36/37-S45-S36/37/39-S26 |
RIDADR | UN 2924 3/PG 2 |
WGK Germany | 1 |
RTECS | TT2100000 |
Packaging Group | II |
Hazard Class | 8 |
HS Code | 2815200000 |
Precursor 0 | |
---|---|
DownStream 10 | |
HS Code | 2815200000 |
---|
Synergistic activity of tenofovir and nevirapine combinations released from polycaprolactone matrices for potential enhanced prevention of HIV infection through the vaginal route.
Eur. J. Pharm. Biopharm. 88(2) , 406-14, (2014) Polycaprolactone (PCL) matrices were simultaneously loaded with the antiviral agents, tenofovir (TFV) and nevirapine (NVP), in combination to provide synergistic activity in the prevention of HIV tran... |
|
Engineering the oxygen sensing regulation results in an enhanced recombinant human hemoglobin production by Saccharomyces cerevisiae.
Biotechnol. Bioeng. 112(1) , 181-8, (2014) Efficient production of appropriate oxygen carriers for transfusions (blood substitutes or artificial blood) has been pursued for many decades, and to date several strategies have been used, from synt... |
|
Detailed characterization of a long-term rodent model of critical illness and recovery.
Crit. Care Med. 43(3) , e84-96, (2015) To characterize a long-term model of recovery from critical illness, with particular emphasis on cardiorespiratory, metabolic, and muscle function.Randomized controlled animal study.University researc... |
kizutasaponin K10 |
Potassium h |
Potassium hydroxide |
EINECS 215-181-3 |
lpotassum hydroxide |
potassium hydroxyde |
potassium hyroxide |
potassium hydroxid |
Caustic potash |
MFCD00003553 |
Cauloside D |